Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.5.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Current assets    
Cash and cash equivalents $ 1,049,478 $ 1,201,112
Restricted cash 724,458 503,397
Accounts and other receivables 74,283 5,749
Inventory 66,322 18,125
Other current assets 75,941 54,203
Total current assets 1,990,482 1,782,586
Non-current restricted cash 31,726 31,722
Property, plant and equipment, net 18,729,177 16,193,907
Debt issuance costs, net 336,474 378,677
Non-current derivative assets 20,715 30,887
Goodwill 76,819 76,819
Other non-current assets 251,458 314,455
Total assets 21,436,851 18,809,053
Current liabilities    
Accounts payable 48,676 22,820
Accrued liabilities 589,604 427,199
Current debt, net 1,677,476 1,673,379
Deferred revenue 26,709 26,669
Derivative liabilities 72,002 35,201
Other current liabilities 54 0
Total current liabilities 2,414,521 2,185,268
Long-term debt, net 17,789,074 14,920,427
Non-current deferred revenue 7,500 9,500
Non-current derivative liabilities 311,207 79,387
Other non-current liabilities 50,382 53,068
Commitments and contingencies (see Note 15)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued 0 0
Common stock, $0.003 par value, Authorized: 480.0 million shares at June 30, 2016 and December 31, 2015; Issued and outstanding: 235.7 million shares and 235.6 million shares at June 30, 2016 and December 31, 2015, respectively 707 708
Treasury stock: 11.8 million shares and 11.6 million shares at June 30, 2016 and December 31, 2015, respectively, at cost (357,491) (353,927)
Additional paid-in-capital 3,105,728 3,075,317
Accumulated deficit (4,243,204) (3,623,948)
Total stockholders’ deficit (1,494,260) (901,850)
Non-controlling interest 2,358,427 2,463,253
Total equity 864,167 1,561,403
Total liabilities and equity $ 21,436,851 $ 18,809,053